CYP3A4-Catalyzed Simvastatin Metabolism as a Non-Invasive Marker of Small Intestinal Health in Celiac Disease
Belén Morón(University Hospital of Zurich), Govind Makharia(All India Institute of Medical Sciences), Chaitan Khosla(Stanford University), Laila Dafik(Stanford University), Gerhard Rogler(University Hospital of Zurich), Megan A. Albertelli(Stanford University), Thomas R. DiRaimondo(Stanford University), Juha Taavela(Tampere University), Markku Mäki(Tampere University), Prasenjit Das(All India Institute of Medical Sciences), Thomas Kræmer(University of Zurich), Anil K. Verma(McMaster University)
Cited by 44
Related Papers
Extraintestinal Manifestations of Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2015|891
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management
|Gastroenterology|2021|821
Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease
|Science|2017|453
Microbial network disturbances in relapsing refractory Crohn’s disease
|Nature Medicine|2019|452